Clinical Trial Update: Study of Repetitive Transcranial Magnetic Stimulation in Parkinson's Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating repetitive transcranial magnetic stimulation for Parkinson disease has completed; the update confirms the study status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Snippet

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) | Conditions: Parkinson Disease | Phase 2 | Status: COMPLETED